!!Projects per year
Personal profile
Personal profile
In 2021 I finished my doctorate in molecular biology in Santiago, Andrés Bello University, time during which I also worked imparting classes at the same university. My doctoral thesis was in the virology field. At the end of that year 2021, finishing my PhD, I arrived at Berking Biotechnology as a researcher in the area of animal pathogens, generating antibodies in alpacas for diagnosis and treatment. During this time, I took mentoring talks and participated in conversations with the business incubator of the Universidad Austral in Chile. In mid-2023 I moved to the University of Antofagasta to work in the area of vaccine research and, during 2024, I moved back to Santiago to the Central University of Chile as a postdoctoral researcher in the area of photodynamic treatments for multidrug-resistant bacteria.
Research Interests
Microbiology, Antimicrobials, Photodynamics
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Angelica Rosa Andrea Bravo Rozas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Respuesta global al estrés foto oxidativo de bacterias multirresistentes frente al tratamiento fotodinámico
Bravo Rozas, A. R. A. (PI) & Palavecino Beaumont, C. E. (CoI)
1/04/24 → 31/03/25
Project: Research
-
Antimicrobial photodynamic therapy across ESKAPE pathogens: Efficacy, limitations, and a pathogen-adapted framework toward clinical translation
Bravo, A. R., Cuevas, M. F., Rubilar-Huenchuman, M., Ortega-Villanueva, C., Bustamante, V., González, I. A., Burgos-Ravanal, R. & Palavecino, C. E., Dec 2026, In: Pharmacology and Therapeutics. 288, 109110.Research output: Contribution to journal › Review article › peer-review
-
Change in the distribution of Streptococcus pneumoniae serotypes causing invasive pneumococcal disease among pediatric and adult patients in Chile between 2016 and 2023
Bravo, A. R., Fuentes-Díaz, M., Cárdenas, A., Carvajal, J. J., Jaldin, C., Jaldin, D., Pereyra, M. A., García, V., Araya-Orellana, J., Araya-Castillo, M., Roach-Poblete, F., Valdivieso Rios, F., Tabilo-Valenzuela, P. B., Jara, E. L., Bueno, S. M., Kalergis, A. M. & Lay, M. K., 2026, In: Frontiers in Microbiology. 17, 1819434.Research output: Contribution to journal › Article › peer-review
Open Access -
Photodynamic antimicrobial efficacy and mode of action of polypyridyl-based Ru(II) complexes against multidrug-resistant Klebsiella pneumoniae
Cuevas, M. F., Vallejos-Monroy, S., Iglesias, V. A., Bravo, A. R., Cabrera, A. R., Pizarro, G. D. C., Sepúlveda-Salgado, S., Rivas-Astroza, M., González, I. A. & Palavecino, C. E., 2026, (Accepted/In press) In: British Journal of Pharmacology.Research output: Contribution to journal › Article › peer-review
Open Access -
Use of Antimicrobial Photodynamic Therapy to Inactivate Multidrug-Resistant Enterobacter spp. Scoping Review
Bravo, A. R., Cuevas, M. F. & Palavecino, C. E., Jun 2026, In: Drugs and Drug Candidates. 5, 2, 28.Research output: Contribution to journal › Review article › peer-review
Open Access -
VNAR: shark single-domain antibodies for the new era of medical biotechnology
Olivares-Olivares, R. A., Bravo, A. R., Garrido-Soto, C., Carvajal, J. J., Manubens, A., Rivas, M., Bustamente, C., Retamal-Díaz, A., Kalergis, A. M. & Lay, M. K., 2026, In: Frontiers in Immunology. 16, 1716916.Research output: Contribution to journal › Review article › peer-review
Open Access